SSA
GSK icon

Schonfeld Strategic Advisors’s GSK GSK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-360,000
Closed -$13.9M – 2183
2024
Q2 		$13.9M Buy
+360,000
New +$15.1M 0.09% 259

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Schonfeld Strategic Advisors's GSK Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of GSK (GSK) in Q1 2026, closing a stake of 107,251 shares — an estimated $5.26M sold.

Schonfeld Strategic Advisors first reported a position in GSK in Q2 2016 and held it in 26 quarters. The position peaked at $75.7M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 107,251 GSK shares in Q1 2026, an estimated $5.26M.
  • Schonfeld Strategic Advisors first reported a position in GSK in Q2 2016 and held it in 26 quarters.
  • Schonfeld Strategic Advisors's GSK position peaked at $75.7M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.